Target intelligence / Profile preview

Pathogenic factors

Molecular classification
Other
01

Overview

Pathogenic factors, commonly known as virulence factors, are a diverse array of molecules and mechanisms produced by microorganisms such as bacteria, viruses, and fungi to facilitate host infection and disease progression (Casadevall & Pirofski, 2001). These factors allow pathogens to colonize host tissues, evade or suppress the immune system, and obtain essential nutrients (Wu et al., 2008). Representative examples include secreted toxins (e.g., botulinum or Shiga toxins), cell-surface adhesins, and complex protein apparatuses like the Type III secretion system (Galán & Wolf-Watz, 2006). In drug development, targeting these factors is referred to as antivirulence therapy, a strategy aimed at disarming the pathogen rather than killing it, which may minimize the selective pressure for antibiotic resistance (Rasko & Sperandio, 2010). Despite their importance in medicine, the term "Pathogenic factors" is a broad functional category rather than a specific molecular target, and clinical applications require identifying specific proteins or pathways within a single species (NIH, 2023). Drugs such as Bezlotoxumab successfully target specific pathogenic factors, like Clostridioides difficile toxin B, to improve clinical outcomes (Gerding et al., 2018).

Other names
Virulence factorsPathogenicity factorsMicrobial virulence factors
02

Mechanism of action

Neutralization of secreted toxins, inhibition of adhesion to host cells, or blockade of specialized secretion systems to attenuate pathogen virulence.

03

Biological functions

InfectionImmune evasionHost colonizationToxin productionTissue invasion
04

Disease associations

Infection
05

Safety considerations

Potential disruption of commensal microbiotaNarrow spectrum of activity for specific factorsRapid evolution and mutation of microbial factors leading to resistance
06

Interacting drugs

Bezlotoxumab

3 more in the full profile.

07

Biomarkers

Toxin titersPathogen-specific antigen levelsC-reactive protein (CRP)

Beyond the preview

Go deeper on Pathogenic factors.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pathogenic factors.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call